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A study of cardiovascular function under controlled and
spontaneous ventilation in isoflurane-medetomidine
anaesthetized horses
Abstract
Objective To determine, in mildly hypercapnic horses under isoflurane-medetomidine balanced
anaesthesia, whether there is a difference in cardiovascular function between spontaneous ventilation
(SV) and intermittent positive pressure ventilation (IPPV). Study design Prospective randomized clinical
study. Animals Sixty horses, undergoing elective surgical procedures under general anaesthesia: ASA
classification I or II. Methods Horses were sedated with medetomidine and anaesthesia was induced
with ketamine and diazepam. Anaesthesia was maintained with isoflurane and a constant rate infusion of
medetomidine. Horses were assigned to either SV or IPPV for the duration of anaesthesia. Horses in
group IPPV were maintained mildly hypercapnic (arterial partial pressure of carbon dioxide (PaCO2)
50- 60 mmHg, 6.7-8 kPa). Mean arterial blood pressure (MAP) was maintained above 70 mmHg by an
infusion of dobutamine administered to effect. Heart rate (HR), respiratory rate (fR), arterial blood
pressure and inspiratory and expiratory gases were monitored continuously. A bolus of ketamine was
administered when horses showed nystagmus. Cardiac output was measured using lithium dilution.
Arterial blood-gas analysis was performed regularly. Recovery time was noted and recovery quality
scored. Results There were no differences between groups concerning age, weight, body position during
anaesthesia and anaesthetic duration. Respiratory rate was significantly higher in group IPPV.
Significantly more horses in group IPPV received supplemental ketamine. There were no other
significant differences between groups. All horses recovered from anaesthesia without complications.
Conclusions There was no difference in cardiovascular function in horses undergoing elective surgery
during isoflurane-medetomidine anaesthesia with SV in comparison with IPPV, provided the horses are
maintained slightly hypercapnic. Clinical relevance In horses with health status ASA I and II,
cardiovascular function under general anaesthesia is equal with or without IPPV if the PaCO2 is
maintained at 50-60 mmHg.
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Abstract
Objective To determine, in mildly hypercapnic
horses under isoflurane–medetomidine balanced
anaesthesia, whether there is a difference in cardio-
vascular function between spontaneous ventilation
(SV) and intermittent positive pressure ventilation
(IPPV).
Study design Prospective randomized clinical study.
Animals Sixty horses, undergoing elective surgical
procedures under general anaesthesia: ASA classi-
fication I or II.
Methods Horses were sedated with medetomidine
and anaesthesia was induced with ketamine and
diazepam. Anaesthesia was maintained with iso-
flurane and a constant rate infusion of medetom-
idine. Horses were assigned to either SV or IPPV
for the duration of anaesthesia. Horses in group
IPPV were maintained mildly hypercapnic (arterial
partial pressure of carbon dioxide (PaCO2) 50–
60 mmHg, 6.7–8 kPa). Mean arterial blood pres-
sure (MAP) was maintained above 70 mmHg by
an infusion of dobutamine administered to effect.
Heart rate (HR), respiratory rate (fR), arterial blood
pressure and inspiratory and expiratory gases were
monitored continuously. A bolus of ketamine was
administered when horses showed nystagmus.
Cardiac output was measured using lithium
dilution. Arterial blood-gas analysis was performed
regularly. Recovery time was noted and recovery
quality scored.
Results There were no differences between groups
concerning age, weight, body position during
anaesthesia and anaesthetic duration. Respiratory
rate was significantly higher in group IPPV. Signif-
icantly more horses in group IPPV received supple-
mental ketamine. There were no other significant
differences between groups. All horses recovered
from anaesthesia without complications.
Conclusions There was no difference in cardiovas-
cular function in horses undergoing elective surgery
during isoflurane–medetomidine anaesthesia with
SV in comparison with IPPV, provided the horses
are maintained slightly hypercapnic.
Clinical relevance In horses with health status ASA
I and II, cardiovascular function under general
anaesthesia is equal with or without IPPV if the
PaCO2 is maintained at 50–60 mmHg.
Keywords anaesthesia, cardiovascular, horse, hyper-
capnia, ventilation.
Introduction
Respiratory depression is common during anaes-
thesia in clinically healthy horses. It can result in
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arterial hypercapnia, hypoxaemia and acid-base
abnormalities. These changes have been attributed
to hypoventilation, ventilation perfusion inequality
and right-to-left vascular shunt (Gillespie et al.
1969).
Intermittent positive-pressure ventilation (IPPV)
is recognized as a means of improving alveolar
ventilation. However, IPPV may cause detrimental
cardiovascular effects (Cournand et al. 1948; Wea-
ver & Walley 1975; Edner et al. 2005). Under
general anaesthesia, mechanically ventilated nor-
mocapnic horses showed a lower cardiac output
than spontaneously breathing hypercapnic horses
(Hodgson et al. 1986). Suggested mechanisms
include: increased intrathoracic pressure, leading
to a reduction in venous return to the heart,
decreased arterial carbon dioxide partial pressure
(PaCO2) during IPPV, leading to a reduction in
sympathetic drive or a combination of both (Steffey
& Howland 1978; Hodgson et al. 1986). Carbon
dioxide (CO2) induced direct and indirect circulatory
effects in humans and animals. Acting directly, CO2
dilates peripheral arterioles and depresses myocar-
dial contractility in humans (Cullen & Eger 1974). It
also directly stimulates the central nervous system
at several levels. At the vasomotor level, the
stimulation is indirect by initiating afferent impulses
from the peripheral chemoreceptors. Elevation of
PaCO2 evokes potent sympathoadrenal responses
that result in increased myocardial contractility and
systemic arterial blood pressure (Morgan et al.
1966; Prys-Roberts et al. 1968; Cullen & Eger
1974). Previous studies in anaesthetized horses
have indicated that cardiovascular function during
IPPV and normocapnia was more depressed than in
spontaneously breathing hypercapnic horses (Stef-
fey & Howland 1978, 1980; Steffey 1981). One
study with halothane anaesthetized horses provided
evidence that hypercapnia produces positive inotro-
pic and haemodynamic effects and that these effects
were associated with an increase in circulating
catecholamines (Wagner et al. 1990). The cate-
cholamine response was maximal at a PaCO2 in the
range of 60 to 80 mmHg. In contrast with this,
another study showed that hypercapnia in isoflura-
ne-anaesthetized horses elicited a biphasic cardio-
pulmonary response. Mild hypercapnia (PaCO2,
59 ± 3.5 mmHg, 7.9 ± 0.47 kPa) decreased car-
diac output and oxygen delivery despite an increase
in mean arterial blood pressure, while moderate
(PaCO2, 82 ± 4.9 mmHg, 10.9 ± 0.65 kPa) and
severe (PaCO2, 110 ± 12 mmHg, 14.7 ± 1.6 kPa)
hypercapnia produced an augmentation of the
cardiopulmonary performance and oxygen delivery
(Khanna et al. 1995). Arrhythmias were not
observed at any level of hypercapnia. The authors
could not pinpoint the reasons for the unexpected
decrease in heart rate (HR) and cardiac index (CI)
with mild hypercapnia. It is not clear if there is a
difference in the degree of haemodynamic stimula-
tion produced by hypercapnia during halothane
and isoflurane anaesthesia. Wagner et al. (1990)
observed a much greater effect of hypercapnia on
mean arterial blood pressure (MAP), CI and stroke
index in horses under halothane anaesthesia than
did Khanna et al. (1995) during isoflurane anaes-
thesia at a similar level of hypercapnia. Isoflurane
depressed the myocardium less than halothane in
horses (Steffey & Howland 1980). Thus the appar-
ently greater degree of hypercapnia-induced hae-
modynamic stimulation during halothane may
simply be a reflection of the starting point. Differ-
ences in experimental design could also be respon-
sible for the different results, e.g. horses in the study
of Khanna et al. (1995) were ventilated just after
endotracheal intubation throughout anaesthesia,
whereas animals in the study of Wagner et al.
(1990) were spontaneously breathing in the
beginning and IPPV was induced later during
anaesthesia.
Common practice in equine anaesthesia is to
use inhalational anaesthesia for major procedures.
To optimize analgesia and reduce the amount of
inhalational agent necessary to maintain anaes-
thesia and thus improve cardiopulmonary func-
tion, various balanced anaesthetic regimes have
been tested. In a study with 300 equids, isoflu-
rane was combined with a constant rate infusion
(CRI) of medetomidine (Kalchofner et al. 2006).
Only three out of the 300 horses needed mechan-
ical ventilation as no spontaneous respiration was
present. As minimal respiratory depression was an
important feature in this study, this was one
reason to choose this protocol. In comparison
with lidocaine/isoflurane balanced anaesthesia,
medetomidine/isoflurane resulted in better recov-
eries and a reduced need for the application of
intraoperative drugs to deepen anaesthesia (Ringer
et al. 2007). As the present study aimed at
comparing spontaneously breathing horses with
mechanically ventilated horses, isoflurane was
used in combination with medetomidine. We
presumed that, with this combination, spontane-
ous respiration would be present and that the
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amount of drug needed to deepen anaesthesia
(that would influence cardiovascular function)
would be minimal.
The present study aimed to determine whether
the haemodynamic depressant effect produced by
IPPV could be reduced if horses were maintained in
a mildly hypercapnic state during isoflurane–mede-
tomidine anaesthesia.
Material and methods
Study design
Prospective, randomized clinical study.
Animals
Sixty horses undergoing surgery at the Equine
Hospital of the Vetsuisse Faculty of the University of
Zurich were included in the study. Only elective
cases were enrolled with an anticipated anaesthesia
duration over 90 minutes, a minimum body weight
(BW) of 200 kg and an ASA score of I or II. Surgeries
of the head and neck area as well as horses
with cardiac murmurs were excluded. Horses were
determined to be healthy by clinical examination.
Plasma sodium and blood haemoglobin concen-
tration were determined for the cardiac output
measurement. Haemoglobin concentration was
calculated by dividing the haematocrit, which
was measured with a micro-haematocrit reader
(Hawksley; Milan Instruments SA, Plan-les-Ouats/
Geneva, Switzerland) after centrifugation (Haema-
tokrit 20; Hettich Zentrifugen, Tuttlingen, Germany),
by three.
This study was performed in compliance with
institutional guidelines of the Clinic for Horses of the
University of Zurich. All owners signed a consent
form allowing all documentation regarding their
horse to be used for scientific research and publica-
tion.
Study protocol
Pre-anaesthetic data recorded were breed, age,
gender, weight, surgical procedure and body posi-
tion. Horses were of different breeds. Demographic
data of the 60 horses as well as data concerning
type of surgery and recumbency position are listed
in Table 1. There were no significant differences
between groups in age, body weight, gender, type of
surgery and recumbency position.
Food but not water was withheld for 8–14 hours.
Horses were randomly assigned to one of two
groups by computer – generated random numbers
(Rancode 3.6; Nomina GmbH, Munich, Germany):
spontaneous ventilation (group SV) or intermittent
positive pressure ventilation (group IPPV). The
same anaesthetist performed all anaesthetics (KSK).
A 14-gauge · 160 mm catheter (Secalon T; Bec-
ton Dickinson AG, Basel, Switzerland) was placed in
the jugular vein. Sixty minutes before induction,
antibiotics and a non-steroidal anti-inflammatory
drug (flunixin (Flunixine ad us. vet.; Biokema SA,
Crissier, Switzerland) 1 mg kg)1 or phenylbutazone
(Butadion, ad us. vet.; G. Streuli & Co. AG, Uznach,
Switzerland) 4 mg kg)1) were administered by
intravenous (IV) injection. Immediately before
induction of anaesthesia, horses were sedated with
medetomidine (Domitor; Graeub AG, Bern, Switzer-
land) 7 lg kg)1IV; one-third of the dose was
administered in the stable before rinsing the mouth,
the remaining two-thirds were injected in the
Table 1 Demographic data and data concerning type of
surgery, recumbency and anaesthesia duration of horses
undergoing isoflurane–medetomidine anaesthesia during
spontaneous (SV) or controlled ventilation (CV)
Variables Group SV Group CV
Horses included 30 30
Age (years) 8 ± 4 (1–18) 7 ± 5 (1–16)
Body weight (kg) 508 ± 105
(210–630)
522 ± 96
(340–700)
Gender
Male 18 20
Female 12 10
Type of surgery
Arthroscopies 16 14
Fracture repair 2 1
Other orthopaedic procedures 6 6
Urogenital procedure 5 8
Other soft tissue surgeries 1 1
Recumbency
Dorsal 19 21
Right lateral 5 5
Left lateral 6 4
Anaesthetic duration (minutes) 126 ± 32
(75–220)
124 ± 36
(65–225)
Time to standing (minutes) 52 ± 17
(15–80)
59 ± 20
(32–105)
No significant difference between the two groups (p < 0.05).
Data are presented as mean ± standard deviaton (range) (age,
body weight, anaesthetic duration and time to standing) or
number of horses (type of surgery and recumbency).
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induction stall slowly over two minutes. If the horse
was not deeply sedated within 5 minutes (e.g. no
reaction when being approached to administer the
ketamine), additional medetomidine was adminis-
tered to effect and the amount noted. At anaesthesia
time zero, the anaesthetic induction was performed
with ketamine (Narketan ad us. vet.; Ve´toquinol
AG, Belp, Switzerland) 2.2 mg kg)1 and diazepam
(Valium 10 mg; Roche Pharma Schweiz AG, Rein-
ach, Switzerland) 0.02 mg kg)1 IV. Once horses
were laterally recumbent, an endotracheal tube was
placed and horses were hoisted on a padded surgery
table. Anaesthesia was maintained with isoflurane
(Attane Isofluran ad us. vet.; Provet AG, Lyssach,
Switzerland) in oxygen (O2) and air and a CRI of
medetomidine (3.5 lg kg)1 hour)1). Isoflurane was
delivered from a precision vaporizer (Isoflurane
Vapor 19.3; Dra¨gerwerk AG, Lu¨beck, Germany)
and a large animal breathing circuit (LAVC-2000;
JD Medical Distributing Co., Phoenix, AZ, USA).
Medetomidine was diluted with saline (0.9% NaCl)
to a concentration of 0.1 mg mL)1 and adminis-
tered with an infusion pump (Phoenix D; Schoch
Electronics AG, Regensdorf, Switzerland). As soon
as horses were connected to the breathing system,
i.e. approximately 5 minutes after induction,
acepromazine (Prequillan; Arovet AG, Zollikon,
Switzerland) 0.03 mg kg)1 was administered by
intramuscular (IM) injection. In horses in group
IPPV artificial ventilation was commenced immedi-
ately after connection to the breathing system and
continued until the end of anaesthesia using a time-
cycled, pressure-controlled bag in a bottle ventilator
(Bird Mark 8; Medical Solution, Hu¨nenberg, Swit-
zerland). During IPPV, the respiratory rate, the
inspiration: expiration ratio, the inspiratory flow
rate and the peak airway pressure were set on the
ventilator so that the PaCO2 was maintained
between 50 and 60 mmHg (6.7–8 kPa). Peak
airway pressure (PIP) was maintained at 18 to
20 cmH2O. Fraction of inspired oxygen (FiO2) was
kept constant at 0.40–0.50. When arterial oxygen
partial pressure (PaO2) fell below 80 mmHg, the
administration of air was stopped and the flow of
oxygen increased to maintain a constant flow rate.
Ringer’s lactate was infused at a rate of
5 mL kg)1 hour)1. To maintain MAP above
70 mmHg, dobutamine (Dobutrex; Medika AG,
Aesch, Switzerland) was administered. The initial
dose in every horse was 0.63 lg kg)1 minute)1
from the beginning of anaesthesia. When MAP
decreased below 70 mmHg, dobutamine infusion
was increased by half of the initial dose
(0.32 lg kg)1 minute)1). After another 5 minutes,
if MAP was still below 70 mmHg, dobutamine was
increased by a quarter of the initial dose
(0.156 lg kg)1 minute)1) and so on until a max-
imum infusion rate of 1.25 lg kg)1 minute)1. In
the opposite direction, dobutamine administration
was decreased in the same stepwise manner when
MAP reached values > 80 mmHg. The last reduc-
tion step after 0.156 lg kg)1 minute)1 was to stop
the dobutamine infusion when MAP was still >
80 mmHg after another 5 minutes. The total
amount (lg kg)1) administered over the entire
anaesthetic period was calculated. To correct for
individual differences in anaesthetic duration, the
amount of dobutamine was expressed as
lg kg)1 minute)1 [total amount of dobutamine
(lg kg)1)/anaesthesia duration (minutes)] for sta-
tistical analysis. The aim was to keep MAP above
70 mmHg. A urinary catheter was placed following
anaesthetic induction.
Qualitative parameters noted during anaesthesia
were palpebral reflex, spontaneous blinking, nys-
tagmus and movements. A ketamine bolus was
administered (0.1 mg kg)1) IV when horses
showed nystagmus or when they were fighting
the respirator (group IPPV). Thiopental (Pentothal;
Abbott AG, Bar, Switzerland) 0.5–1 mg kg)1 IV
was injected in cases of movement. Ketamine and
thiopental administration was recorded. The fol-
lowing cardiovascular and respiratory variables
were measured continuously with a multiparam-
eter monitor (Datex-Ohmeda Cardiocap/5; Anan-
dic, AVL, Schaffhausen, Switzerland) and noted
every 5 minutes: respiratory rate (fR), HR, arterial
blood pressure, inspiratory and expiratory O2,
expiratory CO2 (PE¢CO2) and inspiratory/expiratory
isoflurane concentrations. Occurrence of cardiac
arrhythmias was noted. Arterial blood pressure
was measured invasively by connecting a facial or
transverse facial arterial catheter (Surflo IV Cath-
eter 22-gauge 1’’; Terumo, Medical Solution
GmbH, Switzerland) to a pressure transducer
(Pressure Transducer DTX/Plus; Becton Dickinson
AG; Allschwil, Switzerland) positioned and zeroed
at the level of the sternal manubrium. Arterial
blood-gas analysis was performed with an i-Stat
portable analyzer system (I-STAT Analyzer and
G3+ Cartrdidges; Axon Lab AG, Baden-Da¨ttwil,
Switzerland). The first analysis was carried out
15 minutes following anaesthetic induction and
then repeated every 30 minutes.
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Cardiac output (CO; L minute)1) was measured
by use of a lithium dilution technique and a
commercial computer (LiDCO cardiac sensor sys-
tems; LiDCO Ltd., Cambridge, UK). The sensor
(a flow through cell housing a lithium-selective
electrode) was connected to the arterial catheter.
For determination of CO 1.5 mL (2.25 mmol) of
lithium chloride 1.5 molar was injected through the
jugular catheter while arterial blood passed through
the sensor at a flow rate (4 mL minute)1) that was
controlled by a small battery operated pump. The
first measurement was performed 45 minutes after
anaesthetic induction and then repeated hourly.
The last measurement was performed at the end of
anaesthesia independent of the last measurement.
Cardiac output determinations were performed at
the end of expiration and before collection of arterial
blood-gas samples. Stroke volume (SV), stroke
volume index (SVI), CI, total peripheral resistance
(TPR), arterial oxygen content (CaO2) and oxygen
delivery ( _DO2) were calculated by the following
formulas:
SV (mL beat1Þ ¼ CO  100=HR;
where CO was measured in L minute)1 and heart
rate (HR) in beats minute)1.
SVI (mL beat1kg1Þ ¼ SV/BW;
where BW was measured in kilograms.
CI (mL kg1minute1Þ ¼ CO/BW:
TPR (dynes seconds cm5Þ ¼ 80(MAP)/CO;
where MAP was measured in mmHg (Klabunde
2005).
CaO2 (mL dL
1Þ ¼ ðHb  1:36  SaO2Þ
þð0:0031  PaO2Þ;
where haemoglobin (Hb; g dL)1) was calculated by
dividing the haematocrit by three, and arterial
oxygen saturation was measured in the arterial
blood-gas sample and declared as decimal; the
constant 1.36 is the amount of oxygen (mL at 1
atmosphere) bound per gram of haemoglobin; the
constant 0.0031 represents the amount of oxygen
dissolved in plasma at 1 atmosphere.
_DO2 (mL kg
1minute1Þ ¼ CI (CaO2=100Þ:
Ten to 20 minutes before the end of surgery
morphine (Morphin HCl 10 mg, Sintetica SA,
Mendrisio, Switzerland) 0.1 mg kg)1 was adminis-
tered IM. Isoflurane and medetomidine were dis-
continued and duration of anaesthesia recorded.
For recovery, horses were sedated with medeto-
midine 2 lg kg)1 IV 5 to 10 minutes after discon-
nection from the anaesthetic system. Ten millilitres
of phenylephrine 0.15% (Phenylephrin HCl 1.5
mg mL)1; G. Streuli & Co. AG, Uznach, Switzerland)
were instilled into the nares to decongest the nasal
cavities. During recovery, oxygen was insufflated
at 15 L minute)1, initially through the endo-
tracheal tube, after extubation via the ventral
nasal meatus. Time of extubation, duration of
lateral and sternal recumbency and total time to
standing from disconnection of the anaesthetic
circuit were recorded. The quality of recovery was
graded on a scale of one (excellent) to five (very
poor) (Table 2).
Statistics
Data were analyzed using a commercially available
software package (Statview 5.1 software; SAS Inc.
Cary, NC, USA). Continuous data were evaluated for
normality using visual inspection of the data using a
percentile histogram and the Kolmogorov-Smirnov
test adapted for quality control of normality. Con-
tinuous data were analyzed using analysis of vari-
ance (ANOVA) with repeated measures. Time was
used as the in-between factor. Factorial data were
analyzed using unpaired t-tests. Categorical data
were analyzed using chi-square tests. Post-hoc cell
contribution was performed according to StatView
5.1. Post-hoc cell contribution is a form of stan-
dardized residual that indicates what each cell in the
table contributes to the chi-square statistics. A value
of >±1.96 indicates a significant contribution of the
respective cell.
A p-value of <0.05 was considered significant.
Data are reported as mean ± standard deviation
(SD).
Table 2 Description of the recovery scores
Score Description
1 Excellent, one attempt to stand, minimal or no ataxia
2 Good, 1–2 attempts to stand, some ataxia, horse calm
3 Fair, several attempts to stand, horse remains calm
4 Poor, more than one attempt to stand, horse excited
5 Very poor, bad recovery with high risk of injury
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Results
There were no significant differences between
groups in total time of anaesthesia and time to
standing (Table 1).
Twelve horses in each group required an addi-
tional dose of medetomidine to achieve deep seda-
tion. In group SV, the mean (min–max) additional
dose of medetomidine was 1.7 (0.6–4) lg kg )1, in
group IPPV, 1.4 (0.51–2.6) lg kg )1.
The aim, to maintain PaCO2 of horses in group
IPPV between 50 and 60 mmHg (6.7–10 kPa) was
successfully achieved. Mean PaCO2 was not differ-
ent between the groups (Fig. 1).
Respiratory rate was significantly higher in group
IPPV (p < 0.05; Fig. 2). Recording of central venous
pressure (CVP) was impossible in 38 horses, as no
typical pressure waves could be identified so TPR
was calculated for all horses.
There were no significant differences in any of the
other measured or calculated parameters between
the groups. Values for CI, SV, SVI, TPR, CaO2 and
_DO2 were not different in time between groups
(Table 3). Also arterial blood-gas parameters and
pH did not differ significantly between groups
(Table 4).
However, there were significant changes over
time in the following parameters: HR increased
between 25 and 115 minutes (p < 0.0001; Fig. 3);
_DO2 (p < 0.05), PCO2 (p < 0.0001; Fig. 1), and
HCO3
) (p < 0.0001) increased between 45 and
105 minutes; pH (p < 0.05) decreased between 45
and 105 minutes in both groups; and MAP
decreased between 15 and 45 minutes in both
groups (p < 0.0001; Fig. 4).
Two horses in group SV and four horses in group
IPPV showed first- or second-degree atrioventicular
blocks on the electrocardiogram. In every case,
these arrhythmias disappeared within 60 minutes
following anaesthesia induction without interven-
tion.
The dose of dobutamine used to maintain MAP
above 70 mmHg was not significantly different
Figure 1 Arterial partial pressure of carbon dioxide
(PaCO2) during spontaneous (SV; n = 25) or controlled
ventilation (CV; n = 25) in horses undergoing isoflurane–
medetomidine anaesthesia. Significant increase over time
in both groups (p < 0.0001). No significant difference
between groups.
Figure 2 Respiratory rate (fR) during
isoflurane–medetomidine anaesthe-
sia in horses during spontaneous
(SV; n = 26) versus controlled (CV;
n = 25) ventilation. *Significant dif-
ference between groups (p < 0.05).
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between groups (SV 0.29 and IPPV 0.36 lg kg)1
minute)1, p = 0.28).
End-tidal isoflurane concentration was similar in
both groups (SV: 1.04 ± 0.122%; IPPV: 0.96 ±
0.09%) and constant over time. In 15 horses in
group SV and in nine horses in group IPPV, the FiO2
was changed from 0.4 to >0.9 because of a
measured PaO2 < 80 mmHg (<10.7 kPa).
The total dose of ketamine to deepen anaesthesia
intraoperatively was not significantly different
between groups (group SV: 0.094 ± 0.019 mg
kg)1 hour)1; group IPPV: 0.098 ± 0.018 mg kg)1
hour)1). But the number of horses, which received
ketamine, was significantly different between
groups: twelve horses in group SV (40%) and 21
horses in group IPPV 70%) received supplemental
ketamine. No horse in any group needed supple-
mental thiopental. Recovery quality was assessed in
group SV with 17 · 1, 9 · 2, and 4 · 3; in group
IPPV with 19 · 1, 7 · 2, 3 · 3, and 1 · 4. All
horses recovered from anaesthesia without compli-
cations.
Discussion
This study was designed as a prospective random-
ized clinical study. Confounding variables were re-
duced as much as possible under clinical
circumstances. In the current study, controlled
ventilation did not produce significant cardiovas-
cular effects during isoflurane–medetomidine bal-
anced anaesthesia in mildly hypercapnic horses.
The impairment of circulation by IPPV has been
demonstrated by numerous techniques. An impor-
tant factor is peak - inspiratory pressure (PIP). In
1948, Cournand et al. showed that cardiac output
in humans decreased more or less in proportion to
the increase in pressure. As airway pressure
increased stroke volume and cardiac output pro-
gressively decreased (Morgan et al. 1966). Also in
horses end-inspiratory pressures of 25 cmH2O pro-
duced more pronounced cardiovascular depression
than end-inspiratory pressures of 20 cmH2O or
spontaneous ventilation (Mizuno et al. 1994). The
influence of CO2 was not tested in this study. In the
group with lower inspiratory pressures as well as in
the spontaneous ventilation group, PaCO2s were
higher. Also in our study, peak inspiratory pressures
were low (18–20 cmH2O) and the horses in both
groups were mildly hypercapnic. In horses, hyper-
capnia is generally associated with improvement
in cardiovascular function (Wagner et al. 1990;
Table 3 Values of cardiac index (CI), stroke volume (SV),
stroke volume index (SVI), total peripheral resistance
(TPR), arterial oxygen content (CaO2) and oxygen delivery
ð _DO2Þ at 45 and 105 minutes after anaesthetic induction
in horses under isoflurane–medetomidine anaesthesia
during spontaneous or controlled ventilation
Variable Group
45 minutes
(n = 58)
105 minutes
(n = 43)
CI (mL kg)1 minute)1) SV 55.3 ± 16.20 53.38 ± 18.73
CV 50.73 ± 14.77 56.82 ± 20.54
SV (mL beat)1) SV 848 ± 270.3 871 ± 262.7
CV 785 ± 294.8 801 ± 222.8
SVI (mL beat)1 kg)1) SV 1.69 ± 0.45 1.71 ± 0.383
CV 1.54 ± 0.523 1.57 ± .329
TPR (dynes
seconds cm)5)
SV 248.2 ± 88.8 245.0 ± 86.3
CV 255.8 ± 62.6 237.0 ± 77.5
CaO2 (mL dL
)1) SV 16.2 ± 1.28 16.4 ± 1.32
CV 15.35 ± 1.89 15.45 ± 1.65
_DO2 (mL kg
)1
minute)1)
SV 8.4 ± 2.06 9.3 ± 1.88*
CV 7.6 ± 2.04 9.2 ± 3.83*
At 45 minutes, cardiac output could not be measured in one
horse of each group for technical reasons (SV n = 29; CV
n = 29). At 105 minutes, cardiac output was measured in 23
horses in group SV and in 20 horses in group CV. Data are
presented as mean ± standard deviation. *Significant increase
over time.
Table 4 Values of pH, arterial carbon dioxide partial
pressure (PaCO2), arterial oxygen partial pressure (PaO2)
and bicarbonate (HCO3
)) at 45 and 105 minutes after
anaesthetic induction in horses under isoflurane–mede-
tomidine anaesthesia during spontaneous or controlled
ventilation
Variable Group
45 minutes
(n = 50)
105 minutes
(n = 50)
pH SV 7.326 ± 0.036 7.328 ± 0.04*
CV 7.328 ± 0.36 7.323 ± 0.041*
PaCO2 (mmHg) SV 51.6 ± 5.90 58.0 ± 6.67*
CV 49.5 ± 5.60 56.4 ± 7.5*
PaCO2 (kPa) SV 6.88 ± 0.79 7.7 ± 0.89*
CV 6.6 ± 0.75 7.52 ± 1.0*
PaO2 (mmHg) SV 107.2 ± 41.46 124.0 ± 45.78
CV 126.3 ± 49.98 128.1 ± 52.41
PaO2 (kPa) SV 14.3 ± 5.53 16.5 ± 6.1
CV 16.8 ± 6.66 17.1 ± 6.99
HCO3
) (mmol L)1) SV 27.0 ± 2.34 29.5 ± 2.47*
CV 26.2 ± 3.26 29.4 ± 3.29*
No significant differences between the two groups (p < 0.05).
*Statistically significant changes over time in pH, PaCO2 and
HCO3
) in both groups. Data are presented as mean ± standard
deviation.
Cardiovascular function in isoflurane–medetomidine anaesthetized horses KS Kalchofner et al.
432  2009 The Authors. Journal compilation  2009 Association of Veterinary Anaesthetists, 36, 426–435
Taylor 1998). An increase in circulating catechol-
amines was associated with an increase in PaCO2
and improved haemodynamics (Gillespie et al.
1969; Weaver & Walley 1975). In the present
study, there was no difference between the groups
concerning haemodynamics. The cardiac indices in
our study were comparable to CIs during isoflura-
ne–medetomidine anaesthesia in the study of Ringer
et al. (2007). Cardiac index was also within a
similar range or even higher compared with studies
in horses using other anaesthesia protocols (Hillidge
& Lees 1975; Umar et al. 2007).
Beside hypercapnia, increased venous admixture
and a large alveolar–arterial oxygen tension differ-
ence are evidence of impaired gas exchange during
general anaesthesia in horses. To prevent atelectasis
formation, the use of oxygen combined with air or
nitrous oxide is recommended. To improve PaO2,
some authors tried to use mechanical ventilation or
increased FiO2 fractions but mostly without success
(Hodgson et al. 1986; Cuvelliez et al. 1990; Nyman
et al. 1990). Positive end-expiratory pressure
(PEEP) has been used successfully to improve
oxygenation of arterial blood. However PEEP suffi-
cient to increase functional residual capacity and
arterial oxygenation, induced a marked reduction in
cardiac output (Wilson & Soma 1990) which
resulted in no improvement or even a decrease in
total oxygen delivery to tissues. In the IPPV group,
we chose a respiratory rate of 8–10 breaths
minute)1, as commonly suggested for controlled
ventilation of healthy adult horses (Steffey 1981).
Although the respiratory rate of the spontaneously
breathing horses was slightly lower, the goal of an
identical PaCO2 in both groups was achieved.
Nevertheless, PaCO2 increased slightly in both
groups during anaesthesia and this was paralleled
by a decrease in pH. Whether this was a result of
increased metabolism and therefore CO2 production,
or decreased ventilation as a result of slightly deeper
anaesthesia levels, cannot be answered. The fact
that this was paralleled by an increase in oxygen
delivery suggests that some improvement of cardio-
vascular function was present.
Acepromazine was part of the anaesthetic proto-
col as it was associated with a reduced mortality
rate in horses (Johnston et al. 2002) and as it
causes vasodilation and thus improved perfusion
(Marntell et al. 2005). Acepromazine was adminis-
tered following anaesthetic induction to standardize
Figure 3 Heart rate (HR) during iso-
flurane–medetomidine anaesthesia in
horses during spontaneous (SV;
n = 26) versus controlled (CV;
n = 25) ventilation. HR increased
between 25 and 115 minutes in both
groups (p < 0.0001).
Figure 4 Mean arterial blood pressure (MAP) in horses
during isoflurane–medetomidine anaesthesia under spon-
taneous (SV; n = 25) or controlled (CV; n = 25) ventila-
tion. MAP is decreasing between 15 and 45 minutes in
both groups (p < 0.0001).
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its application time. To avoid a sudden decrease in
blood pressure, acepromazine was administered IM.
Together with the onset of isoflurane and the
waning medetomidine effect, it induced an initial
decrease in MAP, which was paralleled by an
increase in HR. This increase was likely caused by
a physiological compensation to the decreasing
blood pressure. Furthermore, the dose of dobuta-
mine was increased according to the protocol to
improve blood pressure, simultaneously leading to
an increase in HR. The use of dobutamine clearly
influenced cardiac performance and haemodynam-
ics (Lee et al. 1998) and thus the results of the
present study could have been influenced by its use.
Nevertheless, we chose to use it as we aimed to
mimic the clinical situation, where dobutamine is
dosed according to variations in arterial blood
pressure. The administration of dobutamine was
standardized in both groups and no significant
difference between groups with regard to dobuta-
mine dose rates occurred. Therefore, it is unlikely
that it influenced the results of the present study.
With the currently available technology, lithium
dilution appears to be the best method of measuring
CO in the horse under clinical circumstances (Corley
et al. 2003). Lithium dilution requires catheteriza-
tion of a peripheral artery and a jugular vein. It has
been validated in anaesthetized horses and neonatal
foals (Linton et al. 2000; Corley et al. 2002). One of
the disadvantages of lithium dilution is the inaccu-
racy in the presence of intracardiac shunts. There-
fore, we excluded horses with heart murmurs. This
is not a valid method to exclude intracardiac
shunting, but it is unlikely that healthy, symptom-
free adult horses suffer from significant intracardiac
shunts. To calculate systemic vascular resistance,
CVP should be known. We did not use the values
measured through our central venous catheters as
we failed to record typical pressure waves in many
horses. Probably, the catheters were not long
enough to reach the intrathoracic cavity. Thus,
we removed CVP from the calculation and calcu-
lated TPR (Klabunde 2005).
Ketamine does possess a sympathomimetic effect
and might influence cardiovascular function. Sig-
nificantly more horses in group IPPV received
supplemental ketamine. This was necessary as they
were fighting the ventilator. Under medetomidine–
isoflurane anaesthesia relatively low isoflurane
concentrations were necessary to maintain ade-
quate anaesthesia (Ringer et al. 2007). As a result
of the relatively high PE¢CO2 chosen in this study
and the low isoflurane end-tidal concentration,
horses did not tolerate the ventilator, even though
the effect of medetomidine was sufficient to provide
anaesthesia depth adequate to perform surgery.
Theoretically, it is possible that horses in group
IPPV were more often symphatomimetically stimu-
lated by ketamine. This could lead to a falsification
of the cardiovascular data. To quantify the dimen-
sion of this falsification, the total dose of ketamine
per bodyweight and time unit was calculated. As
there was no significant difference between groups
in the total dose of ketamine and the dose was very
low, the authors concluded that there was no
clinically significant influence on cardiovascular
function caused by ketamine. If there is an error,
cardiovascular parameters in group IPPV were
falsely high. This possible error could have been
avoided by inhibiting the fight against the ventilator
by using increased doses of isoflurane. This would
have negatively influenced cardiovascular function
in group IPPV and this is certainly not an aim of
equine anaesthesia. Simply ignoring the resistance
to the ventilator was not an option in the authors’
opinion, as this would also impair cardiac output.
In conclusion, controlled ventilation in healthy
horses undergoing elective surgical procedures
using isoflurane–medetomidine anaesthesia did not
impair cardiovascular function when they were
slightly hypoventilated maintaining mild hypercap-
nia. It is unknown if cardiovascular function would
have been impaired if the horses in group IPPV
would have been maintained normocapnic. It has to
be emphasized that the horses used in this study
were elective patients, assigned to ASA classification
I or II. Whether the same kind of IPPV has no
negative cardiovascular effects in compromised
horses remains to be determined.
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